本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Enanta Pharmaceuticals Inc.

14.60
+0.51003.62%
盤後14.600.00000.00%19:20 EST
成交量:33.40萬
成交額:482.07萬
市值:4.21億
市盈率:-3.80
高:14.66
開:14.07
低:13.89
收:14.09
52周最高:15.34
52周最低:4.09
股本:2,886.26萬
流通股本:2,083.05萬
量比:1.15
換手率:1.60%
股息:- -
股息率:- -
每股收益(TTM):-3.8381
每股收益(LYR):-3.8381
淨資產收益率:-84.63%
總資產收益率:-16.23%
市淨率:6.51
市盈率(LYR):-3.80

資料載入中...

公司資料

公司名字:
Enanta Pharmaceuticals Inc.
交易所:
NASDAQ
成立時間:
1995
員工人數:
120
公司地址:
4 Kingsbury Avenue,Watertown,Massachusetts,United States
郵編:
02472
電話:
傳真:
617 607 0530
簡介:
Enanta Pharmaceuticals, Inc.於1995年根據特拉華州法律註冊成立。該公司是一家生物技術公司,利用強大的、化學驅動的方法和藥物發現能力來發現和開發用於病毒學和免疫學適應症的小分子藥物。

董事

名稱
職位
Bruce L. A. Carter
Director and non-executive Chairman of the Board
Jay R. Luly
President, Director and Chief Executive Officer
Kathleen S. Capps
Executive Director, Accounting, Controller and Interim Principal Accounting Officer
Kristine Peterson
Director
Lesley Russell
Director
Mark G. Foletta
Director
Terry Vance
Director
Yujiro S. Hata
Director

股東

名稱
職位
Jay R. Luly
President, Director and Chief Executive Officer
Brendan Luu
Chief Business Officer
Harry R. Trout, III
Vice President, Finance and Interim Principal Financial Officer
Kathleen S. Capps
Executive Director, Accounting, Controller and Interim Principal Accounting Officer
Matthew P. Kowalsky
Chief Legal Officer and Corporate Secretary
Paul J. Mellett
Chief Financial and Administrative Officer
Scott T. Rottinghaus
Chief Medical Officer
Tara L. Kieffer
Chief Product Strategy Officer
Yat Sun Or
Chief Scientific Officer